Login / Signup

Controversies in the diagnosis of polycystic ovary syndrome.

Preetham RaoPriya Bhide
Published in: Therapeutic advances in reproductive health (2020)
Polycystic ovary syndrome is a common endocrinological condition which is found to be prevalent in 5-10% of women of reproductive age. Historically, a combination of anovulation and androgen excess was considered a hallmark in the diagnosis of polycystic ovary syndrome. Addition of ultrasound features of polycystic ovary syndrome has improved the detection of variation in the polycystic ovary syndrome phenotype. Despite the widespread use of consensus diagnostic criteria, there remain several unresolved controversies in the diagnosis of polycystic ovary syndrome. Difficulty arises in methods of assessment and types of androgens to be measured to detect biochemical hyperandrogenism, setting a cut-off value for the diagnosis of clinical hyperandrogenism, setting an ultrasound threshold of antral follicle count to diagnose polycystic ovaries and also diagnosing this condition in adolescence where there is no clear definition for 'irregular cycles'. This article looks at various controversies in the diagnosis of polycystic ovary syndrome.
Keyphrases
  • polycystic ovary syndrome
  • insulin resistance
  • magnetic resonance imaging
  • metabolic syndrome
  • type diabetes
  • depressive symptoms
  • skeletal muscle
  • clinical practice